Similar articles

• NO-aspirins: a class of new anti-inflammatory and antithrombotic agents.

  del Soldato P, Sorrentino R, Pinto A. del Soldato P, et al. Trends Pharmacol Sci. 1999 Aug;20(8):319-23. doi: 10.1016/s0165-6147(99)01353-x. Trends Pharmacol Sci. 1999. PMID: 10431210 Review. No abstract available.
• Hydrogen sulfide-releasing aspirin derivative ACS14 exerts strong antithrombotic effects in vitro and in vivo.

  Pircher J, Fochler F, Czermak T, Mannell H, Kraemer BF, Wörnle M, Sparatore A, Del Soldato P, Pohl U, Krötz F. Pircher J, et al. Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):2884-91. doi: 10.1161/ATVBAHA.112.300627. Epub 2012 Sep 27. Arterioscler Thromb Vasc Biol. 2012. PMID: 23023375
• Aspirin as an antithrombotic agent.

  Silver MJ, Di Minno G. Silver MJ, et al. Prog Drug Res. 1989;33:43-62. doi: 10.1007/978-3-0348-9146-2_2. Prog Drug Res. 1989. PMID: 2687944 Review. No abstract available.
• The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat.

  Herbert JM, Bernat A, Samama M, Maffrand JP. Herbert JM, et al. Thromb Haemost. 1996 Jul;76(1):94-8. Thromb Haemost. 1996. PMID: 8819259
• Evaluation on antithrombotic effect of aspirin eugenol ester from the view of platelet aggregation, hemorheology, TXB2/6-keto-PGF1α and blood biochemistry in rat model.

  Ma N, Liu XW, Yang YJ, Shen DS, Zhao XL, Mohamed I, Kong XJ, Li JY. Ma N, et al. BMC Vet Res. 2016 Jun 14;12(1):108. doi: 10.1186/s12917-016-0738-0. BMC Vet Res. 2016. PMID: 27296110 Free PMC article.